The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lenalidomide with R-IMED (rituximab, ifosfamide, methotrexate, etoposide and dexamethasone) in refractory or relapsed non-GCB diffuse large B-cell lymphoma: A phase II clinical trial.
 
Tongyu Lin
No Relationships to Disclose
 
Fushen Sha
No Relationships to Disclose
 
He Huang
No Relationships to Disclose
 
Zhao Wang
No Relationships to Disclose
 
Suxia Lin
No Relationships to Disclose
 
Xueying Li
No Relationships to Disclose
 
Huangming Hong
No Relationships to Disclose
 
Xiaojie Fang
No Relationships to Disclose
 
Fangfang Li
No Relationships to Disclose
 
Chen Peng
No Relationships to Disclose
 
Quanguang Ren
No Relationships to Disclose
 
Limei Zhang
No Relationships to Disclose
 
Qing Liu
No Relationships to Disclose